CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $31,968,735
- in 3 filings, $32.0M under 10b5-1 plans
Net −$31,968,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −3,569 | $184.57 | $659K | 80,472 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −3,872 | $185.28 | $717K | 76,600 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −4,600 | $186.35 | $857K | 72,000 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −3,900 | $187.16 | $730K | 68,100 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −1,900 | $188.59 | $358K | 66,200 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −6,200 | $189.22 | $1.2M | 60,000 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −1,800 | $190.63 | $343K | 58,200 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −6,200 | $191.09 | $1.2M | 52,000 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −3,398 | $192.40 | $654K | 48,602 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −4,602 | $193.12 | $889K | 44,000 |
| 2026-08-12 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −144 | $180.00 | $26K | 93,656 |
| 2026-08-12 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −223 | $180.57 | $40K | 93,433 |
| 2026-08-12 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −142 | $180.00 | $26K | 170,792 |
| 2026-08-12 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −223 | $180.57 | $40K | 170,569 |
| 2026-06-18 | Scholl Hendrik Peter Chief Medical Officer | Sale | −96 | $143.90 | $14K | 24,904 |
| 2026-06-18 | Scholl Hendrik Peter Chief Medical Officer | Sale | −3,748 | $144.66 | $542K | 21,156 |
| 2026-06-18 | Scholl Hendrik Peter Chief Medical Officer | Sale | −4,861 | $145.43 | $707K | 16,295 |
| 2026-06-18 | Scholl Hendrik Peter Chief Medical Officer | Sale | −1,199 | $146.24 | $175K | 15,096 |
| 2026-06-18 | Scholl Hendrik Peter Chief Medical Officer | Sale | −96 | $147.11 | $14K | 15,000 |
| 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | Sale | −2,054 | $137.61 | $283K | 32,946 |
Page 3 of 10 · 186 trades